Ashok Kumar Vaid

1.7k citations
52 papers · 1.2k · 1 hit paper · h-index 16

Impact in

  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Breast Cancer Treatment Studies

Papers in

    • Colorectal Cancer Treatments and Studies 5
    • Cancer Diagnosis and Treatment 4
    • HER2/EGFR in Cancer Research 3
    • Multiple Myeloma Research and Treatments 3

Ashok Kumar Vaid

49 papers receiving 1.2k citations

Ashok Kumar Vaid's Hit Papers

Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study 2009 · 663 citations
6630+5+11Years since publication200400600

Peers

Ashok Kumar Vaid
Comparison fields: 5 of 81
  • Oncology 702
  • Cancer Research 237
  • Pulmonary and Respiratory Medicine 416
  • Radiology, Nuclear Medicine and Imaging 164
  • Immunology 105
Replace Bo H. Chao with:
Bo H. Chao United States
Elisa Zanardi Italy
Kazuhiko Nakagami Japan
Amer Sami Canada
Anne‐Claire Hardy‐Bessard France
Alain Bols Belgium
Erin Marie Bertino United States
Jeffrey D. Isaacson United States
Anya M. Litvak United States
C Wiltschke Austria
Ashok Kumar Vaid relative to Bo H. Chao United States Bo H. Chao's profile →
Citations per field
00.5×1.5×2×2.4×
Bo H. Chao · 1×
Citations per year

Countries citing papers authored by Ashok Kumar Vaid

Since Specialization
Citations

This map shows the geographic impact of Ashok Kumar Vaid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashok Kumar Vaid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashok Kumar Vaid more than expected).

Fields of papers citing papers by Ashok Kumar Vaid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashok Kumar Vaid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashok Kumar Vaid. The network helps show where Ashok Kumar Vaid may publish in the future.

Co-authors

The 25 scholars most cited alongside Ashok Kumar Vaid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ashok Kumar Vaid Line = papers co-authored together Ashok Kumar Vaid links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
Hit paper breakdown →
2009663
2 201168
3 201645
4 201541
5 201439
6 201538
7 202130
8 202227
9 200626
10 201423
11 201919
12
Breast carcinoma with metastasis to the gallbladder: an unusual case report with a short review of literature.
200618
13 202016
14 200716
15 201716
16 201716
17 201415
18 202014
19 200712
20 202112

About Ashok Kumar Vaid

Ashok Kumar Vaid is a scholar working on Oncology, Hematology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Breast Cancer Treatment Studies (4 papers), Cancer Diagnosis and Treatment (4 papers), Immunotherapy and Immune Responses (4 papers), Cancer Genomics and Diagnostics (3 papers), HER2/EGFR in Cancer Research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Oncology (702 citations), Cancer Research (237 citations), Pulmonary and Respiratory Medicine (416 citations), Radiology, Nuclear Medicine and Imaging (164 citations) and Immunology (105 citations). Ashok Kumar Vaid has collaborated with scholars based in India, United Kingdom and United States. Frequent co-authors include Poonamalle Parthasarathy Bapsy, Sergei Tjulandin, Michaela K. Jahn, Michael Clemens, Michaela Lehle, Cédric Révil, John Robert Mackey, Andrea Feyereislova, Bella Kaufman and Andrew M. Wardley. Their work appears in journals such as Journal of Clinical Oncology, OncoTargets and Therapy, Journal of Thoracic Oncology, Human Vaccines & Immunotherapeutics and Advances in Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact